Ensign Peak Advisors, Inc
Position in NBIX — Neurocrine Biosciences Inc
CIK 1454984
SALT LAKE CITY, UT
Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$23,908,306
+$179,155 QoQ
Shares Held
181,481
+8.5% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $59,723,780 across 18 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (40.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
181,481 | $23,908,306 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
25,292 | $14,997,650 | |
| 3 | ZTS |
Zoetis Inc.
|
108,357 | $12,808,880 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
166,224 | $2,907,257 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,230,402 | |
| 6 | VTRS |
Viatris Inc
|
65,686 | $887,417 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
31,510 | $754,034 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,785 | $342,876 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,908,306 | 181,481 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,729,151 | 167,307 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $25,328,903 | 180,431 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,465,715 | 170,783 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,538,686 | 194,744 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,709,231 | 173,694 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,144,488 | 174,835 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,530,631 | 272,613 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,337,741 | 154,711 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,566,830 | 72,608 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,587,362 | 85,221 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,038,937 | 95,853 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,925,472 | 68,420 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,247,309 | 52,305 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,719,866 | 44,439 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,992,583 | 61,475 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,186,562 | 65,990 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,119,634 | 71,852 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,258,245 | 106,957 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,635,032 | 109,279 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,734,032 | 48,679 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $16,731,384 | 174,558 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $20,006,953 | 208,059 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $16,066,058 | 131,689 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $8,040,495 | 92,900 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||